Bejar Rafael 4
4 · Aptose Biosciences Inc. · Filed Jan 20, 2022
Insider Transaction Report
Form 4
Bejar Rafael
Chief Medical Officer
Transactions
- Award
Employee Stock Option
2022-01-18+600,000→ 600,000 totalExercise: $1.34Exp: 2032-01-17→ Common Shares (600,000 underlying)
Footnotes (1)
- [F1]Fifty percent (50%) of the options vest on 1/18/2023; the remaining 50% vest as follows: 1/3 on 1/18/2024; 1/3 on 1/18/2025; and 1/3 on 1/18/2026.